The GlucoTab® system provides support for nursing staff and physicians involved in the insulin therapy of patients with diabetes on hospital wards. The system improves blood glucose management workflow and automatically suggests correct insulin dosages.

Comprehensive therapy support through GlucoTab

GlucoTab Therapy Algorithms

Evidence-based, clinically tested therapy algorithms support the individual patient’s blood glucose control.

  • Calculation of a safe insulin dose at the start of therapy, prescribed by physicians
  • Daily suggestion for the adjustment of the planned daily insulin dose (by physicians or nursing staff)
  • Dose calculation for each individual insulin dose considers blood glucose level and meal (nursing staff)

Therapy without algorithm support

Prescription and adjustment of the therapy exclusively by physicians.

The dose calculation for nurses is supported by:

  • Bolus calculator for type 1 diabetes / intensive insulin therapy
  • Sliding scale for supplemental insulin

GlucoTab Basal-Bolus Therapy

This is the type of therapy recommended by guidelines for in-patients.
To reduce complications during in-patient therapy, a fixed blood glucose target range is aimed for.

GlucoTab Basal Insulin (BOT/BIT) Therapy

For geriatric patients with less restrictive blood glucose target values or if therapy with basal insulin is sufficient (e.g. after newly initiated insulin therapy)
Therapy intensity depends on the health status

Physician-driven therapy

For patients, whose individual metabolic situation requires special medical therapy.

Patient Self-Management

Flexible documentation if trained patients perform insulin dosing themselves also in inpatient diabetes management.
Patient determines dose himself

GlucoTab Basal-Bolus Therapy

GlucoTab Basal Insulin (BOT/BIT) Therapy

Physician-driven therapy

Patient Self-Management
  • long acting insulin once daily
  • short acting insulin with each meal and to correct high BG values
  • combination with certain oral antidiabetics or incretins possible

  • mainly long-acting insulin once daily
  • in combination with oral antidiabetic drugs and incretins
  • optional addition of short-acting insulin in the morning or with the largest meal of the day

All variants of medication prescription can be freely selected and dosed:

  • long acting insulin
  • short acting insulin
    • fixed dose order
    • supplemental insulin (sliding scale) for high BG values
    • bolus calculator for intensive insulin therapy using carbohydrate factor and correction factor
  • premixed insulin
  • incretins
  • oral antidiabetic drugs

Electronic diabetes medication management system

User-friendly performance and visualisation of all relevant operations for blood glucose management. Open tasks for physicians and nursing staff support the workflow.

GlucoTab Benefits

GlucoTab helps improve the quality of care. This means that each group involved in the treatment process benefits:

Medical staff are better supported and mistakes are avoided. Patients directly benefit from improved treatment, while the organisations that run the healthcare facility benefit from a reduction in costs.

GlucoTab Process

GlucoTab® enables the electronic planning, performance and documentation of all ward specific workflow steps necessary for managing blood sugar. Medical doctors and nurses receive all relevant information context-sensitively. Workflow is additionally supported by unobtrusive visual reminders.

About us

The company „decide Cinical Software GmbH” specializes in solutions that support clinical decisions and processes – GlucoTab for diabetes mellitus is our first product. Thus, we support anyone responsible for treating patients in making decisions – many times a day, with each decision a brand new challenge..

New GlucoTab version 7.0 is in operation since august 2020.

The main new feature is the additional therapy algorithm for basal insulin therapy (BOT/BIT):

  • On the one hand, this therapy regimen is designed for geriatric persons with diabetes, whose blood sugar target values can be set depending on their health status. For people with diabetes, e.g. after newly initiated insulin therapy, basal insulin therapy may also be sufficient.
  • The blood glucose target range and the frequency of insulin titration are determined individually depending on the patient’s health status.
  • Blood glucose control is mainly achieved with a once-daily long-acting basal insulin (optionally in combination with oral antidiabetic drugs or incretins). Correction with short-acting supplemental insulin is only carried out in case of very high blood glucose levels.
  • To avoid a blood glucose increase during the day, bolus insulin can be prescribed once a day in the morning or with the largest meal – basal insulin plus (BOT+/BIT+) therapy.

GlucoTab thus provides algorithm support for two types of therapy: GlucoTab basal bolus therapy and new: GlucoTab basal insulin therapy (BOT/BIT: basal insulin-assisted oral or incretin therapy).

Therapieformen in GlucoTab 7.0

Further improvements

  • The tasks for the adjustment of therapy with one of the two GlucoTab therapy algorithms are now more clearly differentiated and displayed: Regular therapy adjustment may be performed by physicians and nurses (in role “nurse+”). Certain situations require a therapy evaluation, which must be carried out by a physician.
  • Changes have been made to make it easier to recognise when different doses of insulin are administered than were prescribed or suggested by the therapy algorithm. The automatic dose adjustment in the basal bolus therapy algorithm has also been adapted in this respect.
  • It is now also possible to plan a discharge therapy or to document a specific therapy for discharge.

Articles about GlucoTab in the magazine Qualitas

High satisfaction with GlucoTab in routine operation

The article in Qualitas 04-2019 describes the results of the independent evaluation of the extensive pilot phase of GlucoTab in all departments of Hartberg hospital.

Trial with GlucoTab in geriatrics

The Qualitas article 02-2019 describes the clinical trial with GlucoTab with a new algorithm supported therapy regimen for geriatric patients.

Electronic diabetes chart

The article in Qualitas 04-2018 describes GlucoTab as a specialized electronic medication solution for diabetes.

Good blood glucose control…

… in hospital with GlucoTab support: description of the features and results of clinical trials in Qualitas 02-2018.

Resume of a reference customer

After 8 months of use of GlucoTab at Hartberg hospital, KAGes concludes: More safety for patients with diabetes, in Qualitas 01-2018.

The GlucoTab approach

Support of the care process and insulin dosage suggestions for nurses and physicians, this is initially presented in Qualitas 04-2017.